Potentially effective drugs for the treatment of COVID-19 or MIS-C in children: a systematic review.

Zijun WangSiya ZhaoYuyi TangZhili WangQianling ShiXiangyang DangLidan GanShuai PengWeiguo LiQi ZhouQinyuan LiJoy James MafianaRafael González CortésZhengxiu LuoEnmei LiuYaolong Chen

Published in: European journal of pediatrics (2022)

• Overall, the current evidence cannot adequately demonstrate the effectiveness and safety of using remdesivir, glucocorticoids, and IVIG in treating children and adolescents with COVID-19 or MIS-C. • We are calling for the publication of high-quality clinical trials and provide substantial evidence for the development of guidelines.

Keyphrases

coronavirus disease
sars cov
clinical trial
young adults
combination therapy
phase iii
drug induced